Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06827288 · ClinicalTrials.gov registry record · NA
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
A NA study of Opioid Use Disorder, sponsored by RAND.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06827288: Recruiting NA study of Opioid Use Disorder, sponsored by RAND.
NCT06827288 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by RAND. The registered enrollment target is 500 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06827288, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by RAND.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).
Conditions Studied
Interventions
- BEHAVIORAL SUN
- BEHAVIORAL SUN + Telebridge
- BEHAVIORAL ED-ITT
- BEHAVIORAL ED-ITT + BHS
Study Locations (1)
California
- Arrowhead Regional Medical Center - Colton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-10-04 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06827288 shows while recruiting
NCT06827288 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which SUN is the first listed.
NCT06827288 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06827288 about?
NCT06827288 is a clinical study titled "Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder". The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).
What is the current status of trial NCT06827288?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-10-04. Estimated completion is 2028-03-31.
What conditions does trial NCT06827288 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT06827288?
The interventions under investigation include: SUN (BEHAVIORAL), SUN + Telebridge (BEHAVIORAL), ED-ITT (BEHAVIORAL), ED-ITT + BHS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06827288?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06827288 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06827288's enrollment target sits among peer trials
500 35th of 257 higher than 222 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI